Blue light cystoscopy reduces bladder cancer recurrence risk by 38% compared to white light cystoscopy, as shown in the BRAVO study. The BRAVO study used real-world data from 626 veterans, confirming ...
Discover the latest articles and news in related subjects. If a diagnosis of TCC of the bladder is suspected, urinary cytology followed by white-light cystoscopy of the bladder is performed. Although ...
Non-muscle-invasive bladder cancer is labor intensive and costly to manage. Owing to long-term survival rates and life-long monitoring and treatment, it is the most expensive cancer to manage in ...
Cystoscopy and ureteroscopy are diagnostic or therapeutic procedures, usually performed by urologists, or doctors who specialize in diseases of the urinary tract. These procedures use endoscopes to ...
OSLO, Norway, April 29, 2025 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces four abstract presentations at the AUA 2025, highlighting the benefits of Blue Light ...
June 4, 2010 — The US Food and Drug Administration (FDA) has approved hexaminolevulinate HCl (Cysview; GE Healthcare, under license from Photocure ASA) for the detection of non-muscle-invasive ...
Women on CagriSema lost 25% of their body weight in a post hoc trial analysis, while 79.6% of users had digestive side effects. The drug is not approved. Ice Water, Math Quizzes, and Shocks: The 1948 ...
Nov. 12—(StatePoint) When John noticed blood in his urine, he consulted his doctor and was quickly referred to a urologist. (John is a composite character, based on the experiences of real-life ...
A new urine test could spare bladder cancer survivors from a painful follow-up procedure needed to ensure their cancer hasn't come back, researchers report. People who've gotten surgery for high-risk ...
Findings from an interim analysis of data show that the addition of blue light cystoscopy to conventional white light significantly improved clinical outcomes in a group of patients with ...
The Brighterside of News on MSN
New molecular camera could revolutionize bladder cancer screening
MIT researchers created a nanosensor catheter that detects bladder cancer biomarkers far earlier than current tests.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results